Version 1
: Received: 7 June 2020 / Approved: 7 June 2020 / Online: 7 June 2020 (09:20:25 CEST)
How to cite:
Hassan, S.S.; Pal Choudhury, P.; Roy, B. SARS-CoV2 Envelope Protein: Non-Synonymous Mutations and Its Consequences. Preprints.org2020, 2020060072. https://doi.org/10.20944/preprints202006.0072.v1.
Hassan, S.S.; Pal Choudhury, P.; Roy, B. SARS-CoV2 Envelope Protein: Non-Synonymous Mutations and Its Consequences. Preprints.org 2020, 2020060072. https://doi.org/10.20944/preprints202006.0072.v1.
Cite as:
Hassan, S.S.; Pal Choudhury, P.; Roy, B. SARS-CoV2 Envelope Protein: Non-Synonymous Mutations and Its Consequences. Preprints.org2020, 2020060072. https://doi.org/10.20944/preprints202006.0072.v1.
Hassan, S.S.; Pal Choudhury, P.; Roy, B. SARS-CoV2 Envelope Protein: Non-Synonymous Mutations and Its Consequences. Preprints.org 2020, 2020060072. https://doi.org/10.20944/preprints202006.0072.v1.
Abstract
In the NCBI database, as on June 6, 2020, total number of available complete genome sequences of SARS-CoV2 across the world is 3617. The envelope protein of SARS-CoV2 possesses several non-synonymous mutations over the transmembrane domain and (C)-terminus in 0.414\% of these 3617 genomes. The C-terminus motif DLLV has been changed to DFLV and YLLV in the proteins QJR88103 (Australia: Victoria) and QKI36831 (China: Guangzhou) respectively, which might affect the binding of this motif with the host protein PALS1.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.